	Ixekizumab for the treatment of psoriatic arthritis: an Italian multicentric retrospective observational study. Sci Rep Gentileschi S, Terribili R, Gaggiano C, Fiorentini E, Cometi L, Cigolini C, Perrotta FM, Scriffignano S, Di Cato L, Panaccione A, Niccoli L, Cantini F, Benucci M, Li Gobbi F, Delle Sedie A, Vitale A, Lubrano E, Frediani B, Guiducci S. PMID: 41714331 [PubMed - in process]
	A Randomized Clinical Trial: The Comparative Therapeutic Efficacy of Tap Water-UVA, Saltwater-UVA, and Conventional Bath PUVA in Palmoplantar Pustulosis. Photodermatol Photoimmunol Photomed K, Gündo, Botsal, Kar , Kundakç, Erdem C. PMID: 41712670 [PubMed - indexed for MEDLINE]
	Psychological Well-Being of Patients with Moderate-to-Severe Plaque Psoriasis Treated with Tildrakizumab: 28-Week Interim Results from a Multicenter Observational Study in Italy Using the DASS-21 Questionnaire, the BLUE Study. Dermatol Ther (Heidelb) Trovato E, Bonifati C, Ribero S, Scalvenzi M, Narcisi A, Cuccia A, Panasiti V, Richetta AG, Pagnanelli G, Peris K, Rongioletti F, Satolli F, Bardazzi F, Borghi A, Carrera C, Galluzzo M, Lasagni C, Moretti G, Romanelli M, Cozzani E, Guarneri C, Venturini M, Bongiorno MR, Prignano F, Di Lernia V, Taviti F, Persechino S, De Pasquale R, Colonna F, Talamonti M, Costanzo A. PMID: 41712057 [PubMed - as supplied by publisher]
	Macronutrient intakes and associations with psoriasis severity: a cross-sectional analysis of the asking people with psoriasis about lifestyle and eating (APPLE) study. Eur J Nutr Zanesco S, Maruthappu T, Griffiths CEM, Zhang R, Dalrymple KV, Gibson R, Hall WL. PMID: 41711966 [PubMed - in process]
	Persistence and Long-Term Disease Control of Interleukin-17 Inhibitors and Interleukin-23 Inhibitors in Patients with Psoriasis: A Nationwide Cohort Study in Japan. Psoriasis (Auckl) Xu Y, Li T, Chang CL, Zhang Y, Masuda J, Wu GH, Wahking B, Imafuku S, Qiu H. PMID: 41710906 [PubMed]
	Nanocarriers for Psoriasis Treatment: Insights from a Clinical Trial Registered on the Global Clinical Trials Registry Platform. Int J Nanomedicine Tang S, Xiao R, Zeng Z, Xi J. PMID: 41710365 [PubMed - indexed for MEDLINE]
	Sustained improvements in health status and work productivity with bimekizumab in psoriatic arthritis: 2-year results from two phase 3 studies. Rheumatol Adv Pract Tillett W, Gossec L, Husni ME, Morita A, Ink B, Bajracharya R, Healy P, Mørup MF, Walsh JA. PMID: 41710044 [PubMed]
	Budget Impact of Secukinumab in Psoriatic Arthritis Patients with Contraindication to TNF-Alpha Inhibitors. Clinicoecon Outcomes Res Permsuwan U, Dilokthornsakul P, Sawangjit R. PMID: 41710018 [PubMed]
	IL-23 Inhibitors in Psoriasis: What Have We Learnt so Far? J Inflamm Res Megna M, D'Agostino M, Feo F, Ventura V, Tommasino N, Potestio L. PMID: 41709961 [PubMed]
	Comparison of treatment with GP2017 (an adalimumab biosimilar) and reference adalimumab in people with plaque psoriasis: a plain language summary of the ADACCESS trial. Immunotherapy Betteridge N, Blauvelt A, Edgerton C, Fan J, Guerrieri D, Rose L, Brueckmann I, Wang Q. PMID: 41709696 [PubMed - as supplied by publisher]
	Guttate Psoriasis Triggered by Streptococcal Pharyngitis in Older Patients: A Case Report. Am J Case Rep Thomas DE, Gunasekharan A, Yallapragada RK. PMID: 41709535 [PubMed - indexed for MEDLINE]
	IL-23 serum levels and IL23R polymorphisms in psoriasis: a meta-analysis of susceptibility and severity. BMC Immunol Ahmadipanah S, Shariat Rad P, Montaseri M, Nemati H, Sadeghi M, Ramezani M. PMID: 41709148 [PubMed - as supplied by publisher]
	Rational Design of Imidazo[1,2-a]pyridine as an Effective TLR7 Antagonist for the Treatment of Psoriasis: Research Combined with In Silico Study. J Med Chem Yao P, Li X, Li G, Song M, Yu T, Zheng Z, Zhao Y, Li J, Wang D, Zhu Y, Hou Y, Ding J, Shen H, Zhang G, Ji M, Yang H, Li P, Liu Z, Yang P. PMID: 41708477 [PubMed - as supplied by publisher]
	Three-Year Patient-Reported Outcomes From Bimekizumab for Plaque Psoriasis: The BE RADIANT Randomized Clinical Trial With Open-Label Extension. JAMA Dermatol Augustin M, Feldman SR, Warren RB, Armstrong A, Vender R, López-Ferrer A, Dawe WH, Lambert J, Szilagyi B, Hoepken B, Warham R, Gottlieb AB. PMID: 41706476 [PubMed - as supplied by publisher]
	Impact of Nail Psoriasis on Quality of Life: A Turkish Validation Study of NPQ-10 and NAPPA. Skin Appendage Disord Altan Ferhatoglu Z, Zengin M, Yildirim G, Engin B, Serdaroglu S, Goktay F. PMID: 41704948 [PubMed - as supplied by publisher]
	Factors influencing the proliferation of keratinocytes in psoriasis. iScience Liang N, Zhang K. PMID: 41704756 [PubMed]
	Psoriasis beyond the skin: systemic inflammation as a bridge to metabolic and hepatic comorbidities. Inflammopharmacology Karmbir, Faisal SM, Narang RK, Kurmi BD, Kaur K, Sharma A. PMID: 41703364 [PubMed - as supplied by publisher]
	Dyadic and Sexual Functioning in Psoriasis: A Comparative Study in the Turkish Population. Sisli Etfal Hastan Tip Bul Kulacaoglu F, Yildirim YE, Ilyas HY, Ugurlu DY, Solak SS. PMID: 41700200 [PubMed]
	Differential Expression of Endocannabinoid Receptors in Lesional and Non-Lesional Skin of Psoriasis Patients: Insights Into Pathogenesis and Potential Therapeutic Targets. J Cutan Med Surg Turk JN, Kirchhof MG. PMID: 41699832 [PubMed - indexed for MEDLINE]
	Altered subgenual anterior cingulate cortex connectivity in psoriasis patients with depression: a resting-state fMRI case-control study. Ann Gen Psychiatry Liu N, Wang X, Zhang Y, Han X, Yi F, Huo J, Chang T. PMID: 41699678 [PubMed - as supplied by publisher]

Articles 1 - 20 / 27482

Page 1 of 1375



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy